GoodRx (GDRX) 44th Annual J.P. Morgan Healthcare Conference summary

Industry trends and consumer behavior

• Shifts in ACA subsidies and Medicaid coverage are increasing the uninsured and underinsured population, driving more consumers to seek cash options for prescriptions.

• About 90% of users have insurance, but rising underinsurance is pushing more to use alternative savings platforms.

• Drug affordability and accessibility remain central policy themes, but actionable solutions require public-private partnerships.

Retail pharmacy and business model evolution

• Direct contracts now exist with nine of the top ten retailers, improving pharmacy margins and efficiency.

• Brand point-of-sale buy-down programs are making branded prescriptions profitable for pharmacies.

• Store closures, like Rite Aid’s, require active recapture of scripts, with 20–40% typically regained over time.

Subscription and manufacturer solutions growth

• Launched condition-based subscriptions (ED, hair loss, weight loss) in 2025, focusing on branded therapies and industry-leading pricing.

• Manufacturer Solutions drove over 40% year-over-year growth in 2025, fueled by pharma’s shift to direct-to-patient strategies.

• New technology enables targeted outreach to healthcare providers, with 1.4 million HCPs using the platform annually.